Adlyxin for Anxiety

lixisenatide · Investigational / off-label

Last updated 2026-05-28 15:46 UTC

Adlyxin (lixisenatide) is not FDA-approved for treating anxiety. Research indicates that lixisenatide crosses the blood-brain barrier and enhances neurogenesis, but this does not establish efficacy for anxiety.

AI summary of the sources below.

Drug	Adlyxin (lixisenatide)
Condition	Anxiety
Approval status	Investigational / off-label
Research papers	1

Adlyxin is not FDA-approved for anxiety; the research below reflects investigational or off-label study only.

Research on lixisenatide for anxiety (1)

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci · 2012 · 429 citations

Search PubMed ↗